Search all trials

Find therapies in clinical trials near you – page 61

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Rheumatoid arthritis

Not recruiting

Registered drug

Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Cerebral palsy+5

Not recruiting

Investigational

Study on Valbenazine for Treating Dyskinesia in Children and Adults with Cerebral Palsy

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Valbenazine Ditosylate

Contact Research Centre

Colitis ulcerative

Not recruiting

InvestigationalNo placebo

Study on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Upadacitinib

Contact Research Centre

Juvenile spondyloarthritis+2

Not recruiting

Registered drugNo placebo

Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Adalimumab

Contact Research Centre

Essential thrombocythaemia+1

Not recruiting

Registered drugNo placebo

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ropeginterferon Alfa-2B

Contact Research Centre

Clear cell renal cell carcinoma

Not recruiting

Registered drug

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Anastrozole, Letrozole, Exemestane, and Tamoxifen for Women Aged 70+ with Early Stage Breast Cancer

Registered drugNo placebo

Italy

Participants:65+ years
Substances:Anastrozole

Contact Research Centre

Bronchiectasis+1

Not recruiting

Registered drug

Study on the Safety and Tolerance of BI 1291583 in Adults with Cystic Fibrosis Bronchiectasis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Bi 1291583

Contact Research Centre

B-cell type acute leukaemia

Not recruiting

InvestigationalNo placebo

Study on the Safety of Epcoritamab for Children and Young Adults with Relapsed or Refractory Aggressive B-cell Lymphomas

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Epcoritamab

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on Hepatocellular Carcinoma: Evaluating Livmoniplimab and Budigalimab for Patients with Advanced or Metastatic Cancer After First-Line Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 61

805 trials match your criteria

Rheumatoid arthritis

Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Non-small cell lung cancer metastatic

Study Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Cerebral palsy+5

Study on Valbenazine for Treating Dyskinesia in Children and Adults with Cerebral Palsy

Colitis ulcerative

Study on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis

Juvenile spondyloarthritis+2

Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

Essential thrombocythaemia+1

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Clear cell renal cell carcinoma

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Breast cancer

Study on Anastrozole, Letrozole, Exemestane, and Tamoxifen for Women Aged 70+ with Early Stage Breast Cancer

Bronchiectasis+1

Study on the Safety and Tolerance of BI 1291583 in Adults with Cystic Fibrosis Bronchiectasis

B-cell type acute leukaemia

Study on the Safety of Epcoritamab for Children and Young Adults with Relapsed or Refractory Aggressive B-cell Lymphomas

Hepatocellular carcinoma

Study on Hepatocellular Carcinoma: Evaluating Livmoniplimab and Budigalimab for Patients with Advanced or Metastatic Cancer After First-Line Treatment

Non-small cell lung cancer

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.